Healthcare / Medical Care FacilitiesThailand
$8.85
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 21%
FCF escenarios
weak_data · normalized FCF $48.5M · quality 50.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
51/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$2.7B
P/E
13.4x
↓EV/EBITDA
7.2x
↓ROE
5.7%
↑Gross Margin
53.9%
↑Debt/Equity
0.17
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2025 · 4 años de histórico normalizado
Revenue CAGR
+30.0%
FCF CAGR
+5.6%
FCF margin
13.3%
FCF / Net income
1.27x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.88B · net income $198.0M · FCF $251.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2021 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.88B | $1.88B | $2.14B | $1.92B | $659.5M |
| Net Income | $198.0M | $198.0M | $507.7M | $416.3M | $162.8M |
| EBITDA | $434.3M | $434.3M | $768.8M | $596.5M | $242.4M |
| EPS | 0.66 | 0.66 | 1.68 | 1.39 | 0.54 |
| Gross Margin | 53.9% | 53.9% | 59.9% | 59.1% | 52.7% |
| Operating Margin | 14.5% | 14.5% | 28.0% | 27.4% | 32.0% |
| Net Margin | 10.5% | 10.5% | 23.8% | 21.7% | 24.7% |
| Balance Sheet | |||||
| Debt/Equity | 0.17 | 0.17 | 0.20 | 0.10 | 0.89 |
| Current Ratio | 0.78 | 0.78 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $251.3M | $251.3M | $48.5M | $-284.1M | $201.8M |
| Returns | |||||
| ROE | 5.7% | 5.7% | 14.5% | 13.9% | 97.7% |
| Valuation | |||||
| P/E | 13.41 | 13.41 | — | — | — |
| EV/EBITDA | 7.23 | 7.23 | — | — | — |
| P/B | 0.77 | 0.77 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | -11.7% | -11.7% | 11.4% | 190.6% | — |
| EPS Growth | -60.7% | -60.7% | 20.9% | 157.6% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
6.0%
EPS terminal req.
$0.79
Spread vs growth
-66.7%
5Y implied EPS CAGR
7.6%
EPS terminal req.
$0.95
Spread vs growth
-68.3%
10Y implied EPS CAGR
8.8%
EPS terminal req.
$1.53
Spread vs growth
-69.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+0.0%
Start / end P/E
5.3x → 13.4x
EPS bridge
1.68 → 0.66
Residual
-93.8%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.